Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles

Diabetes Care

Volumn 25, Issue 9, 2002, Pages 1597-1602

  Mudaliar, Sunder ^a,b   Mohideen, Pharis ^a,b   Deutsch, Reena ^b,c   Ciaraldi, Theodore P ^b   Armstrong, Debra ^a   Kim, Bo ^d   Sha, Xue ^d   Henry, Robert R ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN GLARGINE; ANTIDIABETIC AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FATTY ACID; GLARGINE; INSULIN; TRITIUM;

ADSORPTION KINETICS; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GLUCOSE TRANSPORT; HUMAN; INSULIN INFUSION; MALE; METHODOLOGY; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; INSULIN; MALE; TRITIUM;

EID: 0036726473     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.9.1597     Document Type: Article

References (17)

1. Kolterman OG, Gray RS, Griffin J, Burstein J, Sinse J, Scarlett JA, Olefsky JM: Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 68:957-969, 1981
2. Olefsky JM: Insulin resistance and insulin action: an in vitro and in vivo perspective. Diabetes 30:148-162, 1981
3. Olefsky JM, Kolterman OG: Mechanisms of insulin resistance in obesity and non-insulin dependent (type II) diabetes. Am J Med 70:151-168, 1981
4. Ciaraldi TP, Olefsky JM: Relationship between deactivation of insulin stimulated glucose transport and insulin dissociation in isolated rat adipocytes. J Biol Chem 255:327-330, 1980
5. Ciaraldi TP, Olefsky JM: Length of acute exposure to insulin regulates the rate of deactivation of insulin stimulated glucose transport in isolated rat adipocytes. Endocrinology 113:1739-1717, 1983
6. Gray RS, Scarlett JA, Griffin J: In vivo deactivation of peripheral, endogenous and pancreatic insulin action in man. Diabetes 31:929-929, 1982
7. Prager RP, Wallace P, Olefsky JM: In vivo kinetics of insulin action on peripheral glucose disposal and endogenous glucose output in normal and obese subjects. J Clin Invest 78:472-481, 1986
8. Freidenberg GS, Suter S, Henry RR, Nolan J, Reichart D, Olfesky JM: Delayed onset of insulin activation of the insulin receptor kinase in vivo in human skeletal muscle. Diabetes 43:118-126, 1994
9. Rosskamp RH, Park G: Long acting insulin analogs. Diabetes Care 22 (Suppl. 2):B109-B113, 1999
10. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T: Time action profile of the long-acting insulin analog insulin glargine (HOE 901) in comparison with those of NPH insulin and placebo. Diabetes Care 23:644-649, 2000
11. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB: Pharmacokinetics and pharmacodynamics of subcutaneous injection of long acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49:2142-2148, 2000
12. McGuire E, Helderman J, Tobin J, Andres R, Bergman M: Effects of arterial verses venous sampling on analysis of glucose kinetics in Man. J Appl Physiol 41:565-573, 1976
13. DeFronzo R, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
14. Rizza RA, Mandarino JL, Gerich J: Dose response characteristics of effect of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639, 1981
15. Finegood D, Bergman R, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusate. Diabetes 30:914-924, 1987
16. Meyer C, Stumvoll M, Dostou J, Welle S, Haymond M, Gerich JE: Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol Endocrinol Metab 282:E428-E434, 2002
17. Shimizu S, Tani Y, Yamada H, Tabata M, Murochi T: Enzymatic determination of serum free fatty acids: a colorimeiric method. Anal Biochem 107:193-198, 1980